Big Tech firms and Wall Street titans have led a string of
layoffs across corporate America in recent weeks. Amgen's move
to trim its workforce shows how rapid interest rate hikes and a
fading boom in demand post pandemic has begun to weigh on the
healthcare sector.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Savio
D'Souza and Rashmi Aich)
(Adds details, background)
Jan 30 (Reuters) - Drugmaker Amgen Inc said on
Monday that it let go about 300 U.S. employees or about 1.2% of
its total workforce, citing recent organizational changes to its
commercial team.
The company had about 24,200 staff members in over 50
countries, as of December 31, 2021, according to its latest
annual regulatory filing with the U.S. Securities and Exchange
Commission.
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.